{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:38Z","timestamp":1774538678734,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R03AG070536"],"award-info":[{"award-number":["1R03AG070536"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26462","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T17:45:23Z","timestamp":1708278323000},"page":"e26462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone\/ethinyl estradiol and drospirenone\/ethinyl estradiol"],"prefix":"10.1016","volume":"10","author":[{"given":"Jennifer","family":"Stalas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"von Bargen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Largmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Vandeventer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiru","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-8090","authenticated-orcid":false,"given":"Feng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26462_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bpobgyn.2014.06.003","article-title":"The combined oral contraceptive pill -- recent developments, risks and benefits","volume":"28","author":"Dragoman","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"Christin-Maitre","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib3","first-page":"90","article-title":"Long-term experience with Enovid among clinic patients: results after 2 and one-half to 6 years of individual patient use","volume":"5","author":"Sturtevant","year":"1970","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.heliyon.2024.e26462_bib4","series-title":"Oral Contraceptive Pills","author":"Cooper","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e26462_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010813.pub2","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2024.e26462_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0024363918816683","article-title":"Systematic review of hormonal contraception and risk of venous thrombosis","volume":"85","author":"Keenan","year":"2018","journal-title":"Linacre Q."},{"key":"10.1016\/j.heliyon.2024.e26462_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.NAJ.0000654304.29632.a7","article-title":"CE: an evidence-based update on contraception","volume":"120","author":"Britton","year":"2020","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.heliyon.2024.e26462_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0018578718795271","article-title":"The newly available FAERS public dashboard: implications for health care professionals","volume":"54","author":"Kumar","year":"2019","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.heliyon.2024.e26462_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-201551","article-title":"Bradycardia due to donepezil in adults: systematic analysis of FDA adverse event reporting System","volume":"81","author":"Morris","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e26462_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-210662","article-title":"The association between use of rivastigmine and pneumonia: systematic analysis of FDA adverse event reporting System","volume":"83","author":"Morris","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e26462_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-220583","article-title":"Dysphagia risk in patients prescribed rivastigmine: a systematic analysis of FDA adverse event reporting System","volume":"89","author":"Bu","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e26462_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","article-title":"Elevated factor VIII levels and risk of venous thrombosis","volume":"157","author":"Jenkins","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmv038","article-title":"Menstrual physiology: implications for endometrial pathology and beyond","volume":"21","author":"Maybin","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.heliyon.2024.e26462_bib14","series-title":"Physiology, Coagulation Pathways","author":"Chaudhry","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e26462_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.heliyon.2024.e26462_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153822","article-title":"Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis?","volume":"20","author":"Marquardt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e26462_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/VHRM.S173259","article-title":"Role of androgens in cardiovascular pathology","volume":"14","author":"Chistiakov","year":"2018","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.heliyon.2024.e26462_bib18","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1538-7836.2010.03930.x","article-title":"17alpha-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor alpha","volume":"8","author":"Cleuren","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e26462_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1089\/jwh.2016.5801","article-title":"Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17beta-estradiol","volume":"26","author":"Caruso","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.heliyon.2024.e26462_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.heliyon.2024.e26462_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib22","doi-asserted-by":"crossref","first-page":"83334","DOI":"10.18632\/oncotarget.19833","article-title":"Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone","volume":"8","author":"Regidor","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e26462_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2019.11.102","article-title":"Systolic blood pressure and mortality in acute symptomatic pulmonary embolism","volume":"302","author":"Quezada","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13625187.2020.1736546","article-title":"Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome","volume":"25","author":"Morgante","year":"2020","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.heliyon.2024.e26462_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.heliyon.2024.e26462_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ogc.2015.07.007","article-title":"Does the progestogen used in combined hormonal contraception affect venous thrombosis risk?","volume":"42","author":"Han","year":"2015","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.heliyon.2024.e26462_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/17512433.2017.1356718","article-title":"Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis","volume":"10","author":"Farris","year":"2017","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.heliyon.2024.e26462_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4933-5-12","article-title":"Hemostasis and ageing","volume":"5","author":"Mari","year":"2008","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.heliyon.2024.e26462_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0034-1384631","article-title":"Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review","volume":"40","author":"Favaloro","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.heliyon.2024.e26462_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2016.01.033","article-title":"Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis","volume":"89","author":"Lieber","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.heliyon.2024.e26462_bib32","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","article-title":"Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors","volume":"8","author":"van Zaane","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e26462_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.50.5.316","article-title":"von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis","volume":"50","author":"Nordborg","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2024.e26462_bib34","first-page":"E794","article-title":"Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans","volume":"263","author":"De Feo","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.heliyon.2024.e26462_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02208345","article-title":"The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica","volume":"14","author":"Schreiber","year":"1995","journal-title":"Clin. Rheumatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024024939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024024939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:29:33Z","timestamp":1769045373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024024939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024024939"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26462","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone\/ethinyl estradiol and drospirenone\/ethinyl estradiol","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26462"}}